Search Results - "Pullarkat, Vinod A" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

A phase II randomized, placebo-controlled, multicenter trial to evaluate the efficacy of cytomegalovirus PepVax vaccine in preventing cytomegalovirus reactivation and disease after allogeneic hematopoietic stem cell transplant

A phase II randomized, placebo-controlled, multicenter trial to evaluate the efficacy of cytomegalovirus PepVax vaccine in preventing cytomegalovirus reactivation and disease after allogeneic hematopoietic stem cell transplant

by Nakamura, Ryotaro, La Rosa, Corinna, Yang, Dongyun, Hill, Joshua A, Rashidi, Armin, Choe, Hannah, Zhou, Qiao, Lingaraju, Chetan Raj, Kaltcheva, Teodora, Longmate, Jeffrey, Drake, Jennifer, Slape, Cynthia, Duarte, Lupe, Al Malki, Monzr M, Pullarkat, Vinod A, Aribi, Ahmed, Devine, Steven, Verneris, Michael R, Miller, Jeffrey S, Forman, Stephen J, Aldoss, Ibrahim, Diamond, Don J
Published in Haematologica (Roma) (01.06.2024)

Get full text

Journal Article

Functional SARS-CoV-2-specific T cells of donor origin in allogeneic stem cell transplant recipients of a T-cell-replete infusion: A prospective observational study

Functional SARS-CoV-2-specific T cells of donor origin in allogeneic stem cell transplant recipients of a T-cell-replete infusion: A prospective observational study

by La Rosa, Corinna, Chiuppesi, Flavia, Park, Yoonsuh, Zhou, Qiao, Yang, Dongyun, Gendzekhadze, Ketevan, Ly, Minh, Li, Jing, Kaltcheva, Teodora, Ortega Francisco, Sandra, Gutierrez, Miguel-Angel, Ali, Haris, Otoukesh, Salman, Amanam, Idoroenyi, Salhotra, Amandeep, Pullarkat, Vinod A, Aldoss, Ibrahim, Rosenzweig, Michael, Aribi, Ahmed M, Stein, Anthony S, Marcucci, Guido, Dadwal, Sanjeet Singh, Nakamura, Ryotaro, Forman, Stephen J, Al Malki, Monzr M, Diamond, Don J
Published in Frontiers in immunology (03.03.2023)

Get full text

Journal Article

$Venetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma$

Venetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma

by Pullarkat, Vinod A, Lacayo, Norman J, Jabbour, Elias, Rubnitz, Jeffrey E, Bajel, Ashish, Laetsch, Theodore W, Leonard, Jessica, Colace, Susan I, Khaw, Seong Lin, Fleming, Shaun A, Mattison, Ryan J, Norris, Robin, Opferman, Joseph T, Roberts, Kathryn G, Zhao, Yaqi, Qu, Chunxu, Badawi, Mohamed, Schmidt, Michelle, Tong, Bo, Pesko, John C, Sun, Yan, Ross, Jeremy A, Vishwamitra, Deeksha, Rosenwinkel, Lindsey, Kim, Su Young, Jacobson, Amanda, Mullighan, Charles G, Alexander, Thomas B, Stock, Wendy
Published in Cancer discovery (01.06.2021)

Get full text

Journal Article

BCL2 Inhibition by Venetoclax: Targeting the Achilles' Heel of the Acute Myeloid Leukemia Stem Cell?

BCL2 Inhibition by Venetoclax: Targeting the Achilles' Heel of the Acute Myeloid Leukemia Stem Cell?

by Pullarkat, Vinod A, Newman, Edward M
Published in Cancer discovery (01.10.2016)

Get full text

Journal Article

Hematopoietic stem cell donor vaccination with cytomegalovirus triplex augments frequencies of functional and durable cytomegalovirus‐specific T cells in the recipient: A novel strategy to limit antiviral prophylaxis

Hematopoietic stem cell donor vaccination with cytomegalovirus triplex augments frequencies of functional and durable cytomegalovirus‐specific T cells in the recipient: A novel strategy to limit antiviral prophylaxis

by La Rosa, Corinna, Aldoss, Ibrahim, Park, Yoonsuh, Yang, Dongyun, Zhou, Qiao, Gendzekhadze, Ketevan, Kaltcheva, Teodora, Rida, Wasima, Dempsey, Shannon, Arslan, Shukaib, Artz, Andrew, Ball, Brian, Nikolaenko, Liana, Pullarkat, Vinod A., Nakamura, Ryotaro, Diamond, Don J.
Published in American journal of hematology (01.04.2023)

Get full text

Journal Article

Overcoming barriers to treating iron overload in patients with lower-risk myelodysplastic syndrome

Overcoming barriers to treating iron overload in patients with lower-risk myelodysplastic syndrome

by Zeidan, Amer M., Pullarkat, Vinod A., Komrokji, Rami S.
Published in Critical reviews in oncology/hematology (01.09.2017)

Get full text

Journal Article

Adoptive transfer of functional SARS‐COV‐2‐specific immunity from donor graft to hematopoietic stem cell transplant recipients

Adoptive transfer of functional SARS‐COV‐2‐specific immunity from donor graft to hematopoietic stem cell transplant recipients

by La Rosa, Corinna, Chiuppesi, Flavia, Park, Yoonsuh, Gendzekhadze, Ketevan, Zhou, Qiao, Faircloth, Katelyn, Kaltcheva, Teodora, Johnson, Daisy, Ortega Francisco, Sandra, Amanam, Idoroenyi, Otoukesh, Salman, Pullarkat, Vinod A., Nakamura, Ryotaro, Diamond, Don J., Forman, Stephen J., Al Malki, Monzr M.
Published in American journal of hematology (01.11.2022)

Get full text

Journal Article

Cytokine gene polymorphisms are associated with response to blinatumomab in B‐cell acute lymphoblastic leukemia

Cytokine gene polymorphisms are associated with response to blinatumomab in B‐cell acute lymphoblastic leukemia

by Jeyakumar, Nikeshan, Aldoss, Ibrahim, Yang, Dongyun, Mokhtari, Sally, Gendzekhadze, Ketevan, Khaled, Samer, O'Donnell, Margaret, Palmer, Joycelynne, Song, Joo Y., Marcucci, Guido, Stein, Anthony S., Forman, Stephen J., Pullarkat, Vinod A., Chen, Wei, Wu, Xiwei, Nakamura, Ryotaro
Published in European journal of haematology (01.06.2021)

Get full text

Journal Article

Outcomes of second allogeneic hematopoietic stem cell Transplantation (Allo-SCT) in patients with acute lymphoblastic leukemia (ALL)

Outcomes of second allogeneic hematopoietic stem cell Transplantation (Allo-SCT) in patients with acute lymphoblastic leukemia (ALL)

by Al Malki, Monzr M, Aldoss, Ibrahim, Forman, Stephen J, Stiller, Tracey, Pullarkat, Vinod A
Published in Clinical lymphoma, myeloma and leukemia (01.06.2015)

Get full text

Journal Article

Quantifying the reduction in immunoglobulin use over time in patients with chronic immune thrombocytopenic purpura receiving romiplostim (AMG 531)

Quantifying the reduction in immunoglobulin use over time in patients with chronic immune thrombocytopenic purpura receiving romiplostim (AMG 531)

by Pullarkat, Vinod A., Gernsheimer, Terry B., Wasser, Jeffrey S., Newland, Adrian, Guthrie, Troy H., de Wolf, Joost Th. M., Stewart, Ron, Berger, Dietmar
Published in American journal of hematology (01.08.2009)

Get full text

Journal Article

Systemic mastocytosis with associated clonal hematological non‐mast‐cell lineage disease: Analysis of clinicopathologic features and activating c‐kit mutations

Systemic mastocytosis with associated clonal hematological non‐mast‐cell lineage disease: Analysis of clinicopathologic features and activating c‐kit mutations

by Pullarkat, Vinod A., Bueso‐Ramos, Carlos, Lai, Raymond, Kroft, Steven, Wilson, Carla S., Pullarkat, Sheeja T., Bu, Xiangdong, Thein, Maung, Lee, M., Brynes, Russell K.
Published in American journal of hematology (01.05.2003)

Get full text

Journal Article

Potential role of platelet FcγRIIA in collagen-mediated platelet activation associated with atherothrombosis

Potential role of platelet FcγRIIA in collagen-mediated platelet activation associated with atherothrombosis

by Calverley, David C, Brass, Elizabeth, Hacker, Michele R, Tsao-Wei, Denice D, Espina, Byron M, Pullarkat, Vinod A, Hodis, Howard N, Groshen, Susan
Published in Atherosclerosis (01.10.2002)

Get full text

Journal Article

Body cavity-based presentation of natural killer cell lymphoma

Body cavity-based presentation of natural killer cell lymphoma

by Pullarkat, Vinod, Medeiros, L JEFFREY, Brynes, Russell
Published in Leukemia & lymphoma (01.02.2005)

Get full text

Journal Article

Mast cell disease associated with acute myeloid leukemia: Detection of a new c‐kit mutation Asp816His

Mast cell disease associated with acute myeloid leukemia: Detection of a new c‐kit mutation Asp816His

by Pullarkat, Vinod A., Pullarkat, Sheeja T., Calverley, David C., Brynes, Russell K.
Published in American journal of hematology (01.12.2000)

Get full text

Journal Article

Pulmonary Engraftment Syndrome: A Unique Complication of Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis

Pulmonary Engraftment Syndrome: A Unique Complication of Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis

by Amanam, Idoroenyi, Otoukesh, Salman, Yang, Dongyun, Rahmanuddin, Syed, Ball, Brian J., Al Malki, Monzr M., Nakamura, Ryotaro, Marcucci, Guido, Forman, Stephen J., Ali, Haris, Pullarkat, Vinod A.
Published in Blood (15.11.2022)

Get full text

Journal Article

Lower-Intensity CPX-351 + Venetoclax for Patients with Newly Diagnosed Acute Myeloid Leukemia Who Are Unfit for Intensive Chemotherapy: Post Hoc Analysis By Disease Risk Subgroups

Lower-Intensity CPX-351 + Venetoclax for Patients with Newly Diagnosed Acute Myeloid Leukemia Who Are Unfit for Intensive Chemotherapy: Post Hoc Analysis By Disease Risk Subgroups

by Lin, Tara L., Baratam, Praneeth, Stuart, Robert K., Walter, Roland B., Winer, Eric S., Faderl, Stefan, Chandrasekaran, Vijayalakshmi, Chakravarthy, Divya, Cheung, Ronald S., Pullarkat, Vinod A.
Published in Blood (15.11.2022)

Get full text

Journal Article

V-FAST: A Phase 1b Master Trial to Investigate CPX-351 Combined with Various Targeted Agents in Patients with Previously Untreated Acute Myeloid Leukemia

V-FAST: A Phase 1b Master Trial to Investigate CPX-351 Combined with Various Targeted Agents in Patients with Previously Untreated Acute Myeloid Leukemia

by Lin, Tara, Mannis, Gabriel N., Erba, Harry P., Levis, Mark, Zou, Heng, Faderl, Stefan, Cheung, Ronald S., Pullarkat, Vinod A.
Published in Blood (05.11.2020)

Get full text

Journal Article

Preliminary Results By Age Group of Treatment with CPX-351 Plus Venetoclax in Adults with Newly Diagnosed AML: Subgroup Analysis of the V-FAST Phase 1b Master Trial

Preliminary Results By Age Group of Treatment with CPX-351 Plus Venetoclax in Adults with Newly Diagnosed AML: Subgroup Analysis of the V-FAST Phase 1b Master Trial

by Pullarkat, Vinod A., Levis, Mark, Mannis, Gabriel N., Strickland, Stephen A, Lin, Tara L., Faderl, Stefan, Chakravarthy, Divya, Chandrasekaran, Vijayalakshmi, Cheung, Ronald S., Erba, Harry P.
Published in Blood (23.11.2021)

Get full text

Journal Article

Phase 1b Study of Lower-Dose CPX-351 Plus Venetoclax As First-Line Treatment for Patients with AML Who Are Unfit for Intensive Chemotherapy: Preliminary Safety and Efficacy Results

Phase 1b Study of Lower-Dose CPX-351 Plus Venetoclax As First-Line Treatment for Patients with AML Who Are Unfit for Intensive Chemotherapy: Preliminary Safety and Efficacy Results

by Uy, Geoffrey L., Pullarkat, Vinod A., Baratam, Praneeth, Stuart, Robert K., Faderl, Stefan, Chandrasekaran, Vijayalakshmi, Wang, Qi, Chakravarthy, Divya, Cheung, Ronald S., Lin, Tara L.
Published in Blood (23.11.2021)

Get full text

Journal Article

A Phase 2 Study of Bezuclastinib (CGT9486), an Oral, Selective, and Potent KIT D816V Inhibitor, in Adult Patients with Advanced Systemic Mastocytosis (AdvSM)

A Phase 2 Study of Bezuclastinib (CGT9486), an Oral, Selective, and Potent KIT D816V Inhibitor, in Adult Patients with Advanced Systemic Mastocytosis (AdvSM)

by Gotlib, Jason, George, Tracy I., Deininger, Michael W., Tashi, Tsewang, Pullarkat, Vinod A., Bose, Prithviraj, Payumo, Francis, Pilla, Amanda, Jolin, Hina, Sachs, Jessica, DeAngelo, Daniel J.
Published in Blood (23.11.2021)

Get full text

Journal Article